Skip to main content

Dienestrol topical Pregnancy and Breastfeeding Warnings

Brand names: Ortho Dienestrol

Dienestrol topical Pregnancy Warnings

Dienestrol has been assigned to FDA pregnancy category X. Estrogens are contraindicated for use during pregnancy. Estrogenic agents have been associated with urogenital abnormalities in offspring that manifest later in life. Vaginal adenosis, squamous cell dysplasia of the uterine cervix and vaginal cancer have developed later in life in female offspring. In the male offspring, the risks of urogenital abnormalities and testicular cancer later in life are increased.

See references

Dienestrol topical Breastfeeding Warnings

There are no data on the excretion of dienestrol into human milk. Other estrogens are distributed into breast milk. Estrogens administered to nursing women have been shown to decrease the quantity and quality of breast milk.

See references

References for pregnancy information

  1. Heinonen O, Shapiro S; Kaufman DW ed., Slone D (1977) "Birth Defects and Drugs in Pregnancy." Littleton, MA: Publishing Sciences Group, Inc., p. 297
  2. "Product Information. Ortho Dienestrol (dienestrol topical)." Ortho McNeil Pharmaceutical

References for breastfeeding information

  1. Committee on Drugs, 1992 to 1993 (1994) "The transfer of drugs and other chemicals into human milk." Pediatrics, 93, p. 137-50
  2. "Product Information. Ortho Dienestrol (dienestrol topical)." Ortho McNeil Pharmaceutical

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer